How AnteoTech's AnteoBind NXT Reached CLIA Market Milestone

AnteoTech (ASX:ADO) shares jumped 21.4% to 3.4 cents after the company said it had finished the first stage of a collaborative immunoassay product development program on schedule. The work focused on AnteoBind NXT, activated magnetic particles designed for the global chemiluminescent immunoassay (CLIA) market.

The particles are meant to improve CLIA assay sensitivity while cutting raw material use and lowering production costs by giving a uniform, oriented antibody alignment on magnetic particles. ADO was the most discussed stock on the HotCopper forums Wednesday for that reason.

Algorae Pharma (ASX:1AI) also moved higher after winning a NSW Health public hospital supply contract covering three years with two optional one-year extensions. The company pursues a dual strategy of AI-driven drug discovery alongside pharmaceutical commercialisation.

Duketon Mining (ASX:DKM) gained 19.1% to 12.5 cents. The company reported significant gold intersections from its Barlee project drilling in Western Australia. Managing director Stuart Fogarty said the latest results showed prospectivity at the Astro, Gromit and Odie targets, each remaining open and requiring follow-up work.

The broader S&P/ASX 200 dropped 38 points in early trading.